0 Items
Select Page

Welcome to The Native Antigen Company

World leading infectious disease reagents from the experts

Whether you need cutting-edge reagents for your research or bulk products for manufacturing we can support your needs

Antigens, Antibodies, Immunoassays

 

We specialise in the development and manufacture of antigens, antibodies and immunoassays for viral and bacterial pathogens. We produce both native and recombinant antigens using our proprietary mammalian system and have decades of experience in bulk and scale production.

Custom and Contract Research Services

 

We can undertake custom projects to manufacture antigens and other proteins, prepare antibodies and develop immunoassays to support your R&D. Our development laboratories are fully staffed by a team of PhD molecular biologists and development scientists who are able to execute projects as short as a few days, through to long-term programmes of a year or more.

MXRA8 Receptor

Highly Specific Flavivirus NS1 Antibodies

The Native Antigen Company has produced an extensive range of mammalian-expressed NS1 proteins, used to raise highly specific and characterised anti-NS1 antibodies for a variety of research and development applications.

Zika Immunoassay Kit

Assay Development Services

The Native Antigen Company’s assay development team has many years of experience in developing high quality assays for infectious disease and other research applications. With our wealth of experience, we offer end-to-end bespoke development with communication at every step to ensure our clients get the high quality assays they need.

Mammalian-Expressed Proteins

Reagents for Ebola Diagnostics

To support the development of novel diagnostics, The Native Antigen Company provides a range of highly purified viral antigens, developed using our proprietary mammalian expression system. Our range includes envelope glycoproteins from both the Zaire and Bundibugyo strains, alongside Ebola VLPs, which contain nucleoprotein, glycoprotein and VP40 antigens.

About The Native Antigen Company

 The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. The company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company’s high-quality reagents are widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.

Our Assay Development Services

The Native Antigen Company’s assay development team has many years of experience in developing high quality assays for infectious disease and other research applications. With our wealth of experience, we offer end-to-end bespoke development with communication at...

Reagents for Rapid Ebola Diagnostics

The Democratic Republic of Congo is in the grips of the second-worst Ebola outbreak it has experienced, which has now been ongoing for a year with little sign of stopping. In this blog, we discuss the important role that diagnostics play in preventing Ebola outbreaks,...

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

10 + 3 =

Live Customer Feedback